Goldman Sachs to bring back technology banker Nick Giovanni, memo says
Goldman Sachs is bringing back Nick Giovanni, who spent more than 20 years at the Wall Street giant in a prior stint, ...
Why Moderna Inc. (MRNA) Crashed on Monday
We recently compiled a list of the The 10 Worst-Performing Stocks on Monday. In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against the other stocks. Ten ...
S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements
The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key ...
Stocks Pressured by US Tariffs
The S&P 500 Index ( $SPX) ( SPY) today is down -0.95%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down -0.51%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down -1.12%. March E-mini S&P ...
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
Moderna price target lowered to $45 from $55 at Bernstein
Bernstein lowered the firm’s price target on Moderna (MRNA) to $45 from $55 and keeps a Market Perform rating on the shares. The firm cites the ...
Moderna (MRNA) Receives a Hold from Bernstein
In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...